Category: Radiopharmaceuticals
Global Radiopharmaceuticals
-
Global Radiopharmaceutical Competitive Landscape Professional Research Report 2024
... designed to target specific organs, tissues, or physiological processes within the body, allowing for the visualization or treatment of specific medical conditions. In diagnostic nuclear medicine procedures, radiopharmaceuticals emit gamma rays that can be detected ... Read More
-
Global SPECT Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. A Single Photon Emission Computed Tomography (SPECT) scan is a type of nuclear imaging test ... Read More
-
Radiopharmaceutical Market Forecasts to 2030 - Global Analysis By Type (Diagnostic, Therapeutic and Other Types), Radioisotope, Source, Application, End User and By Geography
... billion in 2024 and is expected to reach $13.06 billion by 2030 growing at a CAGR of 12.2% during the forecast period. A specific class of pharmaceutical products known as radiopharmaceuticals is made up of ... Read More
-
Radiopharmaceuticals Market by Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine), Procedural Volume (Diagnostic Procedures, Therapeutic Procedures), Application - Global Forecast 2024-2030
... to reach USD 5.48 billion in 2024, at a CAGR 6.47% to reach USD 8.00 billion by 2030. Radiopharmaceuticals are a unique category of medicinal formulations containing radioisotopes that are used in the field of ... Read More
-
Global Radiopharmaceuticals in Nuclear Medicine Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD 4943.7 million in 2023 and is forecast to a readjusted size of USD 6857.2 million by 2030 with a CAGR of 4.8% during review period. Radiopharmaceuticals are used in the field of nuclear medicine ... Read More
-
Global Radiopharmaceuticals in Nuclear Medical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Radiopharmaceuticals, or medicinal radiocompounds, are a group of pharmaceutical drugs containing ... Read More
-
Radiopharmaceuticals Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Oncology, Cardiology, Neurology, Pulmonary, Urology, and Others), Type (Diagnostic and Therapeutic), Tracer Type (Tc-99m, F-18, Ga-68, TL-201, I-131, Fe-59, Lu-171, RB-82 and N-13, Cr-51 and P-32, Sc-46, Sg-269 and Hs-269, and Others), End User (Hospitals and Clinics, Diagnostic Centers, Academic and Research Institutes, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
... F-18, Ga-68, TL-201, I-131, Fe-59, Lu-171, RB-82 and N-13, Cr-51 and P-32, Sc-46, Sg-269 and Hs-269, and Others), End User (Hospitals and Clinics, Diagnostic Centers, Academic and Research Institutes, and Others), and Geography (North America, ... Read More
-
Global Radiopharmaceutical Market Analysis and Forecast 2024-2030
... an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as radioactive tracers in ... Read More
-
Global Radiopharmaceutical Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine ... Read More
-
Global Radiopharmaceutical Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... It is composed of a radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the ... Read More
-
Global Radiopharmaceutical Market Size, Manufacturers, Opportunities and Forecast to 2030
... radioisotope bond to an organic molecule. The organic molecule conveys the radioisotope to specific organs, tissues or cells. The radioisotope is selected for its properties. Radiopharmaceuticals are used in the field of nuclear medicine as ... Read More
-
Global PET Radioisotope (Radiopharmaceuticals in PET Imaging) Market Growth 2024-2030
... visualize and quantify biological processes within the body. The global PET Radioisotope (Radiopharmaceuticals in PET Imaging) market size is projected to grow from US$ million in 2023 to US$ million in 2030; it is expected ... Read More
-
Radiopharmaceuticals Market By End User (Hospitals and Clinics, Medical Imaging Centers, Others), By Radioisotope (Technetium 99m, Gallium 68, Iodine I, Fluorine 18, Copper 64, Strontium 89, Yttrium 90, Radium 223, Actinium 225, Lutetium 177, Copper 67, Terbium 161, Zirconium 89, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic): Global Opportunity Analysis and Industry Forecast, 2024-2033
... 67, Terbium 161, Zirconium 89, Others), By Application (Cancer, Cardiology, Others), By Type (Diagnostic, Therapeutic): Global Opportunity Analysis and Industry Forecast, 2024-2033 The radiopharmaceuticals market was valued at $7.9 billion in 2023 and is estimated ... Read More
-
2024 Global Forecast for Nuclear Medicine/Radiopharmaceuticals Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... or service category is within the NAICS Medical Device Mfg. industry. The product or service category is within the NAICS Medical Device Mfg. industry. The global market is expected to increase from USD xx billion ... Read More
-
Global Theranostics Market Size, Share & Trends Analysis Report By End User, By Product (Radiopharmaceuticals, Diagnostic Imaging, IVD/Biomarker Screening, and Software & Services), By Application, By Regional Outlook and Forecast, 2023 - 2030
... Theranostics Market size is expected to reach $5.4 billion by 2030, rising at a market growth of 15.2% CAGR during the forecast period. North America boasts a well-developed healthcare infrastructure with modern hospitals, diagnostic centers, ... Read More
-
Global Therapeutic Radiopharmaceuticals Market Growth 2024-2030
... Therapeutic Radiopharmaceuticals is forecast to a readjusted size of US$ 4798 million by 2030 with a CAGR of 15.7% during review period. The research report highlights the growth potential of the global Therapeutic Radiopharmaceuticals market. ... Read More
-
Global Diagnostic Radiopharmaceuticals & Contrast Media Market Growth 2024-2030
... growing demand in downstream market, the Diagnostic Radiopharmaceuticals & Contrast Media is forecast to a readjusted size of US$ 11980 million by 2030 with a CAGR of 3.3% during review period. The research report highlights ... Read More
-
The 2025-2030 World Outlook for Nuclear Medicine-Radiopharmaceuticals
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for SPECT Radioisotope Radiopharmaceuticals
... potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly ... Read More
-
The 2025-2030 World Outlook for Diagnostic Radiopharmaceuticals
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Diagnostic Radiopharmaceutical Imaging Agents
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Medical Cyclotrons
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
-
The 2025-2030 World Outlook for Radiopharmaceuticals
... for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-à-vis ... Read More
-
The 2025-2030 World Outlook for Radiopharmaceuticals and Contrast Media
... demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader ... Read More
-
The 2025-2030 World Outlook for Radiopharmaceuticals-Nuclear Medicines
... earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region, and of the globe. These comparative benchmarks allow the reader to quickly gauge a ... Read More
Research Assistance
